SynZeal Research PVT LTD
All Categories
  • All Categories
  • Accessories
  • Accessories & More
  • Butters & Eggs
  • Camera & Video
  • Mornitors
  • Tablets
  • Laptops
  • Handbags
  • Headphone & Speaker
  • Herbs & botanicals
  • Vegetables
  • Shop
  • Laptops & Desktops
  • Watchs
  • Electronic

Prazepam Related Products

SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Prazepam, pharmacopeial and non-pharmacopeial Prazepam impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Prazepam impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Prazepam-related products are thoroughly characterized. Prazepam products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

目录编号: SZ-P167002
CAS 号: 1088-11-5
分子式 : C15H11ClN2O
分子量 : 270.7
投资状态: In Stock
Rel. CAS No : 41631-10-1 (HCl salt) ; 29580-26-5 (HBr salt) ; 61554-09-4 (sodium salt)
SZ-P167002
CAS No:1088-11-5
分子式: C15H11ClN2O
分子量: 270.7
投资状态: In Stock
Rel. CAS No : 41631-10-1 (HCl salt) ; 29580-26-5 (HBr salt) ; 61554-09-4 (sodium salt)
目录编号: SZ-P167003
CAS 号: 2897-00-9
分子式 : C17H16ClNO
分子量 : 285.8
投资状态: Custom Synthesis
SZ-P167003
CAS No:2897-00-9
分子式: C17H16ClNO
分子量: 285.8
投资状态: Custom Synthesis
目录编号: SZ-P167004
CAS 号: 719-59-5
分子式 : C13H10ClNO
分子量 : 231.7
投资状态: In Stock
Rel. CAS No : 403603-27-0 (HCl salt)
SZ-P167004
CAS No:719-59-5
分子式: C13H10ClNO
分子量: 231.7
投资状态: In Stock
Rel. CAS No : 403603-27-0 (HCl salt)
目录编号: SZ-P167005
CAS 号: 1184768-58-8
分子式 : C19H17BrClNO2
分子量 : 406.7
投资状态: Custom Synthesis
SZ-P167005
CAS No:1184768-58-8
分子式: C19H17BrClNO2
分子量: 406.7
投资状态: Custom Synthesis